Business Wire

Despite COVID-19, Deenova Wins First Pharmacy Automation Contracts in Spain

Share

Deenova reported today that its unrivalled market impulse in 2020 unceasingly expands to Spain, with its first public tender won by Deenova from Bellvitge University Hospital and the Catalan Institute of Health, and separately the company Algalasa for private hospitals throughout Spain.

Jose Luis Temes, M.D., Algalasa’s President and former Subsecretary of Health at Spain Ministry of Health, Director of National Health Service in Spain, and Managing Director of multiple Spanish hospitals, including Foundation Jimenez Diaz, Hospital La Paz, and Hospital Queen Sofia, added: "We are very happy and proud to incorporate Deenova solutions to complete our portfolio. In Algalasa we are known experts in providing first class solutions for the automation of medication workflow and medical devices at hospitals and pharmacies. Deenova products have a unique technology and business approach to R.O.I. in the health care market that simultaneously improves patient safety, staff satisfaction, quality and efficiency of the pharmacy processes, utilising a remarkable closed-loop-system process from prescription all the way to bedside administration.”

Fulvio Rudello, Deenova Chief Operating Officer, added: “As Deenova’s team leader in the design of our next generation mechatronics pharmacy robot, it was crucial to set a very high bar for the industry. Our idea and ambition was to deliver a world-class solution not only for oral solid medications, but to fully automatically handle all the packaging pharmaceutical formats of liquid medications, such as vials, syringes, ampoules, and all other formats of patches sachet, and suppositories. Everyone at Deenova is very proud of leap-frogging other automation and robotic products in the industry”.

Bellvitge University Hospital is located in Hospitalet de Llobregat, Barcelona. With its 900+ beds, it is a public tertiary reference center for a community of more than 200.000 inhabitants at the entire southern axis of Catalonia up to the Ebro river, and part of the Catalan Institute of Health. The Bellvitge University Hospital Campus also houses the University of Barcelona, the Catalan Institute of Oncology, and the IDEBELL Research Institute, for more information, refer to https://bellvitgehospital.cat

Deenova is the undisputed leading supplier of combined mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere. Deenova’s unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff. Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%. Please visit www.deenova.com for additional information on its market leading solutions.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Contacts at Deenova:
Christophe Jaffuel, Carlos Duran Ortega, Elisa Mariotti
e.mariotti@deenova.com, +39 0523 785311

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Loop Energy Enters Joint Market Development Agreement With Técnicas Reunidas to Accelerate the Commercialization of Hydrogen-Powered Vehicles5.8.2021 15:00:00 EEST | Press release

Loop Energy (TSX:LPEN), a developer and manufacturer of hydrogen fuel cell-based solutions, announces their joint market development agreement with Técnicas Reunidas (TR) – a global provider of services for investors in hydrogen infrastructure based in Madrid, Spain. Under this agreement, both parties will aim to secure future opportunities that require both TR’s hydrogen know-how and Loop Energy’s fuel cell technology. The initial scope of this joint market agreement focuses on providing hydrogen-based solutions to several key vertical markets: transport agencies, truck, transit and coach bus service fleets, materials handling, warehouse and port logistics including drayage, urban delivery services and stationary power applications. With the assistance of TR’s on-site production and supply equipment, creating hydrogen both via water electrolysis and steam reforming of natural gas, biogas or bioethanol, Loop will be able to provide more convenient and cost-effective hydrogen solutions

Moody's to Acquire RMS, Leader in Climate & Natural Disaster Risk5.8.2021 14:18:00 EEST | Press release

Moody's Corporation (NYSE: MCO) and RMS announced today that they have entered into a definitive agreement for Moody’s to acquire RMS, a leading global provider of climate and natural disaster risk modeling and analytics, for approximately $2.0 billion from Daily Mail and General Trust plc (LON: DMGT). The acquisition will immediately increase Moody’s insurance data and analytics business to nearly $500 million in revenue and will accelerate the development of the Company’s global integrated risk capabilities to address the next generation of risk assessment. With over 400 risk models covering 120 countries, RMS is the world’s leading provider of climate and natural disaster risk modeling serving the global property and casualty (P&C) insurance and reinsurance industries. For the fiscal year ending September 30, 2021, RMS is expected to generate revenue of approximately $320 million1 and adjusted operating income of approximately $55 million1. "Today’s leaders face a complex, interlink

ViacomCBS Partners With Sky to Launch Paramount+ in Europe5.8.2021 14:00:00 EEST | Press release

ViacomCBS Networks International (VCNI), a division of ViacomCBS Inc. (NASDAQ: VIAC, VIACA) and Sky, part of Comcast Corporation (NASDAQ: CMCSA), today announced that Paramount+ will launch on Sky platforms in the UK, Ireland, Italy, Germany, Switzerland and Austria (GSA) in 2022 as part of a new multi-year distribution agreement that also includes the extended carriage of ViacomCBS’ leading portfolio of pay TV channels and the renewal of Sky as an ad sales partner in select markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210805005410/en/ “We are thrilled to expand our long-standing partnership with Sky to continue delivering ViacomCBS’ leading portfolio of premium entertainment brands to Sky customers and importantly bring Paramount+ to new audiences in all Sky markets, including the UK, Ireland, Italy, and GSA,” said Raffaele Annecchino, President and Chief Executive Officer, ViacomCBS Networks International. “This

Final Results from the Longest Hereditary Angioedema Study of Active Treatment Duration Conducted to Date Support the Sustained Safety and Efficacy of TAKHZYRO® (lanadelumab) Injection for Long-Term Prevention of Hereditary Angioedema Attacks5.8.2021 14:00:00 EEST | Press release

Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) (“Takeda”) today announced the publication of the final results from the Phase 3 HELP (Hereditary Angioedema Long-term Prophylaxis) Study™ Open-label Extension (OLE) designed to evaluate the long-term safety (primary endpoint) and efficacy of TAKHZYRO® (lanadelumab) 300mg every two weeks for up to 2.5 years. The study results show that preventative treatment with TAKHZYRO markedly reduced the frequency of hereditary angioedema (HAE) attacks in patients 12 years of age and older who received treatment for a mean duration of almost 2.5 years (29.6 months; 8.2 standard deviation).1 The data were published online this month in the journal Allergy. Secondary endpoints of the study showed the mean (min;max) HAE attack rate observed in the study population (N=209) was reduced by 87.4 percent (-100; 852.8) overall versus baseline, and attacks requiring acute treatment (N=106) were reduced by 93.4 percent (-100; -52.8).1 Reductions were

Vedanta Aluminium Becomes India’s Largest Green Power Purchaser5.8.2021 13:48:00 EEST | Press release

Vedanta Aluminium Business, India’s largest producer of aluminium and value-added products, became India’s largest green power purchaser at the Indian Energy Exchange Limited (IEX) in Q1 FY22. For its largest integrated aluminium production facility at Jharsuguda, in Odisha (India), Vedanta procured 354 million units of solar and non-solar renewable energy primarily from IEX’s Green Term-Ahead Market (GTAM). Purchase of green power from GTAM has enabled organisations like Vedanta to achieve their carbon-mitigation targets while producing ‘green’ value-added products. Vedanta Aluminium’s purchase of green power units is more than 35% of the green power traded on IEX in Q1 FY22. Speaking about Vedanta’s approach towards carbon mitigation, Mr. Rahul Sharma, CEO – Vedanta Aluminium Business said, “Our sustainability imperatives are designed to fulfil our climate impact reduction targets, which are in complete alignment with the goals of Paris Agreement and Nationally Determined Contributio

ISAE-SUPAERO Continues Its Involvement in the InSight Mission and Reveals the Results of Its Research From Planet Mars5.8.2021 11:24:00 EEST | Press release

Launched by NASA in May 2018, the InSight mission is pursuing the objective of studying the internal structure of the planet Mars using the SEIS seismometer developed by ISAE-SUPAERO. Three studies, published on July 23 in the journal Science, reveal, for the first time, an estimate of the size of the core, the thickness of the crust and the structure of the mantle of the red planet. Three of the co-authors, Raphaël Garcia, Mélanie Drilleau and Nicolas Compaire, are from ISAE-SUPAERO, and are collaborating on this major seismic exploration project, which represents a significant step in the understanding of the formation and thermal evolution of Mars. Before this mission, the internal structure of Mars was still poorly understood. The details of the planet's internal structure and the depth of the boundaries between crust, mantle and core were completely unknown. With the successful deployment of the SEIS experiment on the surface of Mars in early 2019, the scientists collected and ana

Yamaha Motor Earnings Continue to Rise in Second Quarter5.8.2021 11:12:00 EEST | Press release

Yamaha Motor Co., Ltd. (TOKYO:7272) announces its consolidated business results for the first half of fiscal 2021. Net sales for the consolidated accounting period for the first six months of the fiscal year ending December 31, 2021 were 920.1 billion yen (an increase of 234.6 billion yen or 34.2% compared with the same period of the previous fiscal year) and operating income was 109.2 billion yen (an increase of 90.1 billion yen or 471.9%). Ordinary income was 115.1 billion yen (an increase of 94.3 billion yen or 454.8%) and net income for the period attributable to owners of parent was 93.1 billion yen (compared to a quarterly net loss of 2.8 billion yen in the same period of the previous fiscal year). For net sales, the worldwide spread of COVID-19 infections since March last year led to lower unit sales and production numbers, but the impacts have diminished over this first half of the fiscal year and demand has recovered in all business segments, resulting in higher sales overall.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom